Dr. Alexandra S. Heerdt, MD

Dr. Heerdt practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Heerdt's NPI, 1114906591, was assigned on January 12, 2006. Dr. Heerdt graduated from Sidney Kimmel Medical College in 1987. Dr. Heerdt holds New York license 175788.

Dr. Heerdt's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Heerdt's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Heerdt to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heerdt practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Heerdt's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Heerdt is board certified in surgery by the American Board of Surgery. Dr. Heerdt is licensed in New York.

Dmand AI lists breast reconstruction and mastectomy among the conditions Dr. Heerdt treats.

CMS data shows 906 Medicare services from Dr. Heerdt across 9 procedure codes in 2024, for 622 Medicare patients. Medicare paid $127,691 for them. Every service was in an office.

CMS counts 622 Medicare patients who saw Dr. Heerdt in 2024. The largest group is 65 to 74, with 349 patients. 75% of them have cancer, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Heerdt's median patient age at 67, with 96% women.

In 2024, Dr. Heerdt wrote 19 Medicare Part D claims for 11 patients. 58% of them were for generic drugs. They cover 2 drugs, with $19,706 in total drug cost. In 2019, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Heerdt for performance year 2024, reported as part of a group. Dr. Heerdt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 104 procedures of mastectomy by Dr. Heerdt, more than 99% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 49 papers to Dr. Heerdt, published from 2007 to 2024. 2013 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Sentinel Lymph Node Biopsy and Axilla. Dr. Heerdt has published most often in Ann Surg Oncol. Dr. Heerdt's most frequent co-authors are Hiram S. Cody, MD, Patrick I. Borgen, MD and Monica Morrow, MD.

Dmand AI links Dr. Heerdt to 1 clinical trial. Conditions studied include Lymphedema and Motor Activity.

Dmand AI lists 3 awards for Dr. Heerdt, most recently New York Magazine: Top Doctors in 2014.

Dr. Heerdt graduated from Sidney Kimmel Medical College in 1987. Dr. Heerdt is a member of ACS and ASCO.

Dr. Heerdt is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.